stockrow
Friday 6 November 2026
Export POCI’s income statement to Excel — free account
Precision Optics Corp.
POCI Healthcare Medical Instruments & Supplies
Precision Optics Corp.’s revenue for fiscal 2026 (year ended June 2026) was $31.5 million, up 65.2% from fiscal 2025.
- Revenue
- +42.0%
- EPS
- +94.4%
- Free cash flow
- −45.6%
- Total debt
- −31.0%
Quarter to June 2026, against a year earlier
4.88
0.07
−1.41%
Follow POCI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (22.26%) | (29.62%) | (73.56%) | (57.98%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 3 | 3 | |
| (13.93%) | (18.49%) | (34.24%) | (30.82%) | ||
ROIC |
(18.59%) | (27.38%) | (41.96%) | (32.76%) | |
Return on Tangible Assets |
(29.83%) | (40.79%) | (473.78%) | (190.60%) | |
Average Days of Receivables |
68.81 | 82.97 | 72.83 | 70.85 | |
Free Cash Flow per Share |
(0.23) | (0.22) | (0.39) | (0.45) | |
Free Cash Flow |
(1.98) | (1.75) | (3.04) | (3.51) | |
Capital Expenditures |
(0.43) | (0.43) | (0.57) | (0.51) | |
| Other line items | |||||
Cash ROIC |
(6.29%) | (5.43%) | (25.78%) | (24.98%) | |
Accounts Receivable Turnover |
6.13 | 5.79 | 5.83 | 5.90 | |
Accounts Payable Turnover |
8.04 | 6.15 | 5.02 | 5.96 | |
Inventory Turnover |
7.06 | 6.76 | 5.44 | 5.00 | |
Average Days of Payables |
50.10 | 91.35 | 100.07 | 79.77 | |
Days of Inventory on Hand |
53.55 | 54.20 | 70.59 | 77.22 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.28% | 3.65% | 4.10% | 4.95% | |
Selling, General and Administrative Expense of Revenue |
25.08% | 26.64% | 33.17% | 37.38% | |
Share Based Compensation of Revenue |
3.61% | 4.61% | 6.73% | 8.18% | |
Interest Coverage |
(23.68) | (29.74) | (36.71) | (28.83) | |
Operating CF/Net income |
0.43 | 0.27 | 0.36 | 0.49 | |
Depreciation/Fixed assets |
0.31 | 0.31 | 0.26 | 0.24 | |
Capex/Depreciation |
(1.54) | (1.62) | (2.25) | (2.21) | |
Revenue per Share |
3.70 | 3.71 | 3.16 | 2.80 | |
Operating CF per Share |
(0.18) | (0.17) | (0.32) | (0.39) | |
Capex per Share |
(0.05) | (0.06) | (0.07) | (0.07) | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 2 Nov 2026